Cataract Global Clinical Trials Review, H1, 2015

Date: June 11, 2015
Pages: 79
Price:
US$ 2,500.00 US$ 2,000.00
Offer valid until December 31, 2016!
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: CBAA3D9900EEN
Leaflet:

Download PDF Leaflet

Cataract Global Clinical Trials Review, H1, 2015

SUMMARY

GlobalData's clinical trial report, 'Cataract Global Clinical Trials Review, H1, 2015' provides an overview of Cataract clinical trials scenario. This report provides top line data relating to the clinical trials on Cataract. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

REASONS TO BUY
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Introduction
Cataract
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Cataract to Ophthalmology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Cataract to Ophthalmology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of Cataract
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Cataract Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Cataract
Apr 20, 2015: Icon Bioscience Announces Pivotal Phase 3 Clinical Data Demonstrates Exceptional Efficacy of IBI-10090 in Reducing Inflammation Associated with Cataract Surgery
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Valeant Pharmaceuticals International, Inc.
Clinical Trial Overview of Valeant Pharmaceuticals International, Inc.
Novartis AG
Clinical Trial Overview of Novartis AG
Innovative Medical Products
Clinical Trial Overview of Innovative Medical Products
Actavis plc
Clinical Trial Overview of Actavis plc
Laboratoires Thea S.A.
Clinical Trial Overview of Laboratoires Thea S.A.
InSite Vision Incorporated
Clinical Trial Overview of InSite Vision Incorporated
Bucci Laser Vision
Clinical Trial Overview of Bucci Laser Vision
Omeros Corporation
Clinical Trial Overview of Omeros Corporation
Bausch & Lomb Incorporated
Clinical Trial Overview of Bausch & Lomb Incorporated
Abbott Laboratories
Clinical Trial Overview of Abbott Laboratories
Clinical Trial Overview of Top Institutes / Government
NHS Trusts Clinical Trials
Clinical Trial Overview of NHS Trusts Clinical Trials
Indiana University School of Medicine
Clinical Trial Overview of Indiana University School of Medicine
Moorfields Eye Hospital NHS Foundation Trust
Clinical Trial Overview of Moorfields Eye Hospital NHS Foundation Trust
Department of Health, UK
Clinical Trial Overview of Department of Health, UK
National Eye Institute
Clinical Trial Overview of National Eye Institute
All India Institute of Medical Sciences
Clinical Trial Overview of All India Institute of Medical Sciences
Arak University of Medical Sciences
Clinical Trial Overview of Arak University of Medical Sciences
Capital Medical University
Clinical Trial Overview of Capital Medical University
Federal University of Sao Paulo
Clinical Trial Overview of Federal University of Sao Paulo
Het Oogziekenhuis Rotterdam
Clinical Trial Overview of Het Oogziekenhuis Rotterdam
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Cataract Therapeutics, Global, Clinical Trials by Region, 2015
Cataract Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015
Cataract Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015
Cataract Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015
Cataract Therapeutics Clinical Trials, Europe, Top Five Countries, 2015
Cataract Therapeutics Clinical Trials, North America, Top Countries, 2015
Cataract Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015
Cataract Therapeutics Clinical Trials, Central and South America, Top Countries, 2015
Proportion of Cataract to Ophthalmology Clinical Trials, G7 Countries (%), 2015
Cataract Therapeutics, G7 Countries, Clinical Trials by Phase, 2015
Cataract Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015
Proportion of Cataract to Ophthalmology Clinical Trials, E7 Countries (%), 2015
Cataract Therapeutics, E7 Countries, Clinical Trials by Phase, 2015
Cataract Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015
Cataract Therapeutics, Global, Clinical Trials by Phase, 2015
Cataract Therapeutics, Global, Clinical Trials In Progress by Phase 2015
Cataract Therapeutics, Global, Clinical Trials by Trial Status, 2015
Cataract Therapeutics Clinical Trials, Global, by End Point Status, 2015
Cataract Therapeutics, Global, Suspended Clinical Trials, 2015
Cataract Therapeutics, Global, Withdrawn Clinical Trials, 2015
Cataract Therapeutics, Global, Terminated Clinical Trials, 2015
Cataract Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
Cataract Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015
Cataract Therapeutics Clinical Trials, Global, Key Sponsors, 2015
Cataract Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015
Cataract Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2015
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Innovative Medical Products, 2015
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2015
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires Thea S.A., 2015
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by InSite Vision Incorporated, 2015
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Bucci Laser Vision, 2015
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Omeros Corporation, 2015
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Bausch & Lomb Incorporated, 2015
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2015
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by NHS Trusts Clinical Trials, 2015
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University School of Medicine, 2015
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Moorfields Eye Hospital NHS Foundation Trust, 2015
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2015
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2015
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2015
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Arak University of Medical Sciences, 2015
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital Medical University, 2015
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2015
Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Het Oogziekenhuis Rotterdam, 2015

LIST OF FIGURES

Cataract Therapeutics, Global, Clinical Trials by Region (%), 2015
Cataract Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015
Cataract Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015
Cataract Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015
Cataract Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015
Cataract Therapeutics Clinical Trials, North America, Top Countries (%), 2015
Cataract Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015
Cataract Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015
Proportion of Cataract to Ophthalmology Clinical Trials, G7 Countries (%), 2015
Cataract Therapeutics, G7 Countries, Clinical Trials by Phase, 2015
Cataract Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015
Proportion of Cataract to Ophthalmology Clinical Trials, E7 Countries (%), 2015
Cataract Therapeutics, E7 Countries, Clinical Trials by Phase, 2015
Cataract Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015
Cataract Therapeutics, Global, Clinical Trials by Phase (%), 2015
Cataract Therapeutics, Global, Clinical Trials In Progress by Phase, 2015
Cataract Therapeutics, Global, Clinical Trials by Trial Status, 2015
Cataract Therapeutics Clinical Trials, Global, by End Point Status, 2015
Cataract Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
Cataract Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015
Cataract Therapeutics Clinical Trials, Global, Key Sponsors, 2015
Cataract Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015
Cataract Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015
GlobalData Methodology

COMPANIES MENTIONED

Valeant Pharmaceuticals International, Inc.
Novartis AG
Innovative Medical Products
Actavis plc
Laboratoires Thea S.A.
InSite Vision Incorporated
Bucci Laser Vision
Omeros Corporation
Bausch & Lomb Incorporated
Abbott Laboratories
Skip to top


Thrombophilia Global Clinical Trials Review, H1, 2016 US$ 2,125.00 Mar, 2016 · 57 pages
Colitis Global Clinical Trials Review, H1, 2016 US$ 2,125.00 Mar, 2016 · 72 pages
Dysphagia Global Clinical Trials Review, H1, 2016 US$ 2,125.00 Mar, 2016 · 60 pages
Hyperalgesia Global Clinical Trials Review, H1, 2016 US$ 2,125.00 Mar, 2016 · 94 pages

Ask Your Question

Cataract Global Clinical Trials Review, H1, 2015
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: